All Posts: COVID-19
-
NHS Professor Develops New Course on Social Determinants of COVID-19
Category: GUMC Stories
-
Vaccines Alone May Not Be Enough to End Pandemic
WASHINGTON (March 18, 2021) — Even as vaccines are becoming more readily available in the U.S., protecting against the asymptomatic and pre-symptomatic spread of the virus (SARS-CoV-2) that causes COVID-19 is key to ending the pandemic, say two Georgetown infectious disease experts. In their Perspective, “SARS-CoV-2 Transmission Without Symptoms,” published March 18 in the journal […]
Category: News Release
-
Georgetown Ethicist Collaborates with Physicians to Create Moral Framework for Elective Surgeries During COVID-19
Category: GUMC Stories
-
Answering the Call: Georgetown Coordinates COVID-19 High-Capacity Vaccination Site
Category: GUMC Stories
-
Global Health Graduate Course Features COVID-19-Focused Simulation Exercise
Category: GUMC Stories
-
Two Georgetown Centers Find Unexpected Synergy in Exploring Pandemic’s Impact in Latin America
(February 26, 2021) — Proving that scholarly sparks can fly in unexpected ways, a cross-campus collaboration between Georgetown University Medical Center and the Edmund A. Walsh School of Foreign Service is applying a holistic new lens to COVID-19. Drawing on each center’s unique expertise, undergraduate and graduate students from the Center for Global Health Science […]
Category: GUMC Stories
-
Georgetown Mission and Ministry Offers Ignatian Retreat for Alumni Caregivers
Category: GUMC Stories
-
Clinical Students Volunteer With COVID-19 Vaccinations
(February 19, 2021) — Since mid-January, more than 150 medical and nursing students at Georgetown have answered MedStar Health’s call for volunteers to administer the COVID-19 vaccine. Coordinated by Elizabeth Zolper (M’21), the students volunteer every day of the week at four MedStar Health locations around Washington, D.C. Throughout this pandemic, students have contributed to […]
Category: GUMC Stories
-
Georgetown Professor Comments on FDA Authorization of Vaccine to Prevent COVID-19
WASHINGTON (December 11, 2020) — This evening, the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for the BioNTech/Pfizer vaccine. Former FDA Chief Scientist and infectious disease physician Jesse Goodman, MD, MPH, professor of medicine at Georgetown University Medical Center, celebrates and provides a brief perspective on this historic moment: “The first emergency use authorization […]
Category: News Release
-
Shutting Down COVID-19 Virus’s Destructive Proteins with Aerosolized Molecules
WASHINGTON (November 13, 2020) — Researchers at Georgetown University Medical Center have successfully used molecules comprised of small strands of RNA to shut down the production of destructive proteins generated by the COVID-19 virus. Additionally, the researchers are working to aerosolize the RNA molecules so that they could be incorporated in an inhalable drug that […]
Category: News Release